Iteos Therapeutics Inc ITOS:NASDAQ

RT Quote | NASDAQ | USD
Last | 08/12/22 EDT
25.36quote price arrow up+1.66 (+7.00%)
Volume
468,078
52 week range
16.21 - 52.43
Loading...
  • Open24.01
  • Day High26.12
  • Day Low23.59
  • Prev Close25.36
  • 52 Week High52.43
  • 52 Week High Date01/03/22
  • 52 Week Low16.21
  • 52 Week Low Date05/24/22

Key Stats

  • Market Cap901.29M
  • Shares Out35.54M
  • 10 Day Average Volume0.31M
  • Dividend-
  • Dividend Yield-
  • Beta1.5
  • YTD % Change-45.53

KEY STATS

  • Open24.01
  • Day High26.12
  • Day Low23.59
  • Prev Close25.36
  • 52 Week High52.43
  • 52 Week High Date01/03/22
  • 52 Week Low16.21
  • 52 Week Low Date05/24/22
  • Market Cap901.29M
  • Shares Out35.54M
  • 10 Day Average Volume0.31M
  • Dividend-
  • Dividend Yield-
  • Beta1.5
  • YTD % Change-45.53

RATIOS/PROFITABILITY

  • EPS (TTM)8.64
  • P/E (TTM)2.94
  • Fwd P/E (NTM)10.77
  • EBITDA (TTM)385.077M
  • ROE (TTM)63.40%
  • Revenue (TTM)497.30M
  • Gross Margin (TTM)-
  • Net Margin (TTM)59.85%
  • Debt To Equity (MRQ)0.00%

EVENTS

  • Earnings Date11/08/2022(est)
  • Ex Div Date-
  • Div Amount-
  • Split Date-
  • Split Factor-

Latest On Iteos Therapeutics Inc

There is no recent news for this security.

Profile

MORE
iTeos Therapeutics Inc. is a clinical-stage biopharmaceutical company. The Company is focused on the discovery and development of differentiated immuno-oncology therapeutics for patients with cancer. The Company's pipeline includes two clinical-stage programs: EOS-448 and Inupadenant. The Company’s lead antibody product candidate, EOS-448, is an antagonist of T-cell immunoreceptor with Ig and ITIM domains (TIGIT), an immune checkpoint with multiple mechanisms of action, which...
David Hallal
Non-Executive Independent Chairman of the Board
Michel Detheux Ph.D.
Chief Executive Officer, Director
Matthew Call
Chief Operating Officer
Matthew Gall
Chief Financial Officer
Address
321 Arsenal Street
Bldg 312, Floor 3, Suite 301
Watertown, MA
02472
United States

Top Peers

SYMBOLLASTCHG%CHG
NVTA
Invitae Corp
5.37+0.86+19.07%
RGNX
Regenxbio Inc
33.37+0.25+0.75%
HLTH
Cue Health Inc
4.54+0.04+0.89%
ALEC
Alector Inc
13.20+0.54+4.27%
CHRS
Coherus BioSciences Inc
13.76+1.11+8.77%